PUBLISHER: TechNavio | PRODUCT CODE: 1774430
PUBLISHER: TechNavio | PRODUCT CODE: 1774430
The ai in oncology market is forecasted to grow by USD 7,540.1 mn during 2024-2029, accelerating at a CAGR of 27.8% during the forecast period. The report on the ai in oncology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing volume and complexity of oncological data, growing demand for personalized medicine and precision oncology, and accelerating technological advancements in ai and computational infrastructure.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 23.3% |
CAGR | 27.8% |
Incremental Value | $7,540.1 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's ai in oncology market is segmented as below:
By Component
By Type
By Application
By Geographical Landscape
This study identifies the rise of multimodal ai and integrated diagnostics as one of the prime reasons driving the ai in oncology market growth during the next few years. Also, intensified focus on clinical workflow integration and scalability and increasing regulatory scrutiny and the demand for real-world evidence will lead to sizable demand in the market.
The report on the ai in oncology market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ai in oncology market vendors that include BenevolentAI, ConcertAI, Inc., F. Hoffmann La Roche Ltd., Freenome Holdings Inc., GE Healthcare Technologies Inc., Google LLC, International Business Machines Corp., Koninklijke Philips NV, Lunit Inc., Microsoft Corp., NVIDIA Corp., Owkin Inc., PAIGE LLC, PathAI Inc., Recursion Pharmaceuticals Inc., Siemens Healthineers AG, SOPHiA GENETICS, and Tempus Labs Inc.. Also, the ai in oncology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: